INVA Q4 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$80M+14.9% YoY

Gross Profit

$80M100.0% margin

Operating Income

$77M96.7% margin

Net Income

$264M330.3% margin

EPS (Diluted)

$2.34

QoQ Revenue Growth

+29.5%

Cash Flow

Operating Cash Flow

$62M

Free Cash Flow

$62M

Stock-Based Comp.

$486,000

Balance Sheet

Total Assets

$548M

Total Liabilities

$389M

Stockholders' Equity

$154M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$70M	+14.9%
Gross Profit	$80M	$69M	+15.4%
Operating Income	$77M	$66M	+16.3%
Net Income	$264M	$58M	+351.8%